Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.2000 (-0.4%) ($29.7900 - $30.7900) on Wed. Jul. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.71% (three month average) | RSI | 51 | Latest Price | $30.2000(-0.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(58%) ARKG(56%) IBUY(54%) IWC(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.355% in a week (0% probabilities). VIXM(-28%) UUP(-15%) VXX(-12%) TBT(-7%) IYT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.355% (StdDev 4.71%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
Resistance Level | $31.51 | 5 Day Moving Average | $31.5(-4.13%) | 10 Day Moving Average | $32.01(-5.65%) | 20 Day Moving Average | $31.51(-4.16%) | To recent high | -12.8% | To recent low | 36% | Market Cap | $1.876b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |